Outcome of laser Treatment for Retinopathy of Prematurity
Article Sidebar
-
Retinopathy of prematurity, Laser photocoagulation, intravitreal anti-VEGF
Abstract
Introduction & Objectives
Retinopathy of prematurity is a proliferative disorder that requires urgent treatment. Proper case
finding and treatment will prevent permanent blindness in infants. Laser photocoagulation is an
preferred technique for the treatment of ROP. Aim of this study to describe the result of laser
indirect Ophthalmoscopy in Makassar, South Sulawesi, Indonesia.
Methods
This is Observational retrospective study, from 1130 screening procedures during 2020 until 2022.
This study found 41 ROP patients who had received therapy.
Results
From 43 patients who received therapy, most were ROP stage 3 (80%), APROP (19%) and the rest
were Stage IV A . 40 infants received lasers photocoagulation, and one infant received both laser
photocoagulation and intravitreal anti-VEGF. Regression was found in all cases of stage 3 ROP.
Patients with aggressive posterior ROP also were treated successfully, except one patient
progressed to stage 4 ROP.
Conclusion
with screening and prompt treatment, good outcomes have been obtained for infants with ROP
Full text article
References
Hong EH, Shin YU, Cho H, Retinopathy of prematurity: a review of epidemiology and current treatment strategies , Department of Ophthalmology, Hanyang University College of Medicine, Seoul, Korea, Clin Exp Pediatr Vol. 65, No. 3, 115–126, 2022
Foroozan R, Connolly BP, Tasman WS. Outcomes after laser therapy for threshold retinopathy of prematurity. Ophthalmology. 2001 Sep;108(9):1644-6.
Edy Siswanto J, Sauer PJ. Retinopathy of prematurity in Indonesia: Incidence and risk factors. J Neonatal Perinatal Med. 2017;10(1):85-90.
Chan DFF, Herrera-Arroyo MM. Anatomic outcomes of laser indirect ophthalmoscopy for retinopathy of prematurity in a tertiary referral center in the Philippines. BMC Res Notes. 2019 May 10;12(1):263.
An International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005; 123:991-999.
Badriah C, Amir I, Elvioza, Ifran, Karianni BE. Prevalence and risk factors of retinopathy of prematurity. Paediatrica Indonesiana. 2012;52(3):138-44.
Indrawati RP, Kuntorini MW. Karakteristik Pasien Retinopathy of Prematurity di Pusat Mata Nasional Rumah Sakit Mata Cicendo Periode Januari 2018 - Desember 2020. Bandung: Universitas Padjadjaran; 2022.
Shan H, Ni Y, Xue K, Yu J, Huang X. Type 1 Retinopathy of Prematurity and Its Laser Treatment of Large Preterm Infants in East China. PLoS One. 2015 Dec 16;10(12):e0144313.
de las Rivas Ramírez, N., Luque Aranda, G., Rius Díaz, F. et al. Risk factors associated with Retinopathy of Prematurity development and progression. Sci Rep 12, 21977 (2022).
Flynn JT, Chan-Ling T. Retinopathy of prematurity: two distinct mechanisms that underlie zone 1 and zone 2 disease. Am J Ophthalmol. 2006; 142(1):46–59.
Authors
Copyright (c) 2023 Idayani Panggalo, Habibah S Muhidin, Andi Muhammad Ichsan, Budu, Andi Suryanita, Dyah Ayu Windy
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.